Infection of mammalian cells with herpes simplex virus (HSV) results in the production of a number of virus-induced soluble antigens. Immunodiffusion analyses of the soluble antigen mixture (SAM) obtained from HSV-infected KB or BHK cells revealed at least six well-defined immunoprecipitin bands. Calcium phosphate chromatography (Brushite) was employed to separate one immunoprecipitin (designated CP-1) from the remaining viral and host antigens. We conclude that CP-1 is a viral-specific antigen because (i) specific antiserum, which had been repeatedly absorbed with uninfected cell extracts or serum components, still retained the capacity to react in gel diffusion with CP-1 antigen; (ii) anti-CP-1 serum reacted in gel diffusion with SAM, yielding one precipitin band in identity with the band formed against human gamma globulin; (iii) the CP-1 fraction stimulated the production of HSV-neutralizing antibody of high capacity. The last observation suggests that fraction CP-1 contains a biologically active structural component of the virus which is associated with the envelope. The CP-1 immunoprecipitin was separated from SAM by an alternative method by using a cyanogen bromide-linked immunosorbent prepared from anti-CP-1 gamma globulin. The observation that the CP-1 antigen isolated from the immunosorbent effectively blocked serum-neutralizing activity provided further evidence that neutralizing antibody was directed against CP-1. Acrylamide gel electrophoresis and immunological experiments suggest that the CP-1 antigen is in part a glycoprotein. The finding that CP-1 contains only one antigenic component of the virus will permit future biological studies to be made with a monoprecipitin antiserum. In addition, the techniques described in this paper represent initial steps in the purification of HSV antigens.
and characterize HSV-soluble antigens, no simple and reproducible method has been described (27, 28, 30, 32) .
This report describes a method for the isolation of an HSV-specific immunoprecipitin from a mixture of other viral-induced antigens. Our studies suggest that this antigenic moiety is a structural component of the viral envelope.
MATERIALS AND METHODS Cell cultures. Monolayer cultures of KB cells were propagated in 32-oz (0.95-liter) bottles containing Eagle minimal essential medium (MEM) supplemented with 10% calf serum. BHK cells were propagated in 32-oz bottles or roller bottles by using MEM supplemented with 5% fetal calf serum.
Virus and virus titration. HSV (strain HF) was used throughout. This strain elicits syncytium formation in BHK cells and rounded cells in KB cultures. The preparation of high-titered virus stocks and plaque titrations was performed as described previously (3) , but omitting the agar overlay and with 5%/c fetal calf MEM as a maintenance medium.
Soluble antigen preparations. Monolayer cultures of KB or BHK cells were infected at an input multiplicity of 5 to 10 plaque-forming units (PFU) per cell. The cells were harvested after 18 to 24 hr, washed three times with phosphate-buffered saline (PBS), pH 7.2, and concentrated by centrifugation (10 min at 800 X g). The cell pellet was suspended in PBS to a final concentration of 2 X I 07 cells per ml and treated for 45 sec in a 60-w MSE Sonifier (Measuring and Scientific Equipment Ltd., London). Such preparations were centrifuged for 2 hr at 100,000 X g, after which the supernatant fluids were collected, dialyzed overnight against 0.01 M phosphate buffer (pH 7.2), and finally concentrated (usually three-to fourfold) in a Diaflo ultrafiltration chamber with an XM-50 membrane (Amicon Corp.). Protein concentration was determined by the method of Lowry et al. (9) by using crystalline bovine serum albumin as a standard. This crude material was termed the soluble antigen mixture (SAM). Prior to preparation of antisera, antigen preparations were rendered free from infectious virus by the following procedure: HSV-SAM was centrifuged at 100,000 X g for 2 hr at 4 C. The top two-thirds of the supernatant fluid was aspirated and centrifuged once more at 100,000 X g. This procedure was repeated for a third time. The efficacy of this procedure for the removal of infectious virus was monitored by virus titration. Even after several blind passages through BHK cell monolayer, the final antigen preparation failed to produce plaques.
Preparation of antisera. Antisera directed against viral-induced soluble antigen(s) were prepared by immunizing rabbits with a series of three intramuscular injections of the appropriate antigen suspended in Freund complete adjuvant. Ten days after the last injection, the rabbits were boosted intravenously with adjuvant-free antigen. All antisera were absorbed with extracts of uninfected KB or BHK cells and calf serum to remove antibody directed against nonviral components. Serum was considered absorbed when it did not react by immunodiffusion with uninfected cell extracts at a concentration of 8 mg of protein per ml. This concentration of protein was 2 to 30 times greater than in the viral antigenic fractions used for immunodiffusion. Human gamma globulin was obtained commercially (Dow Chemical Co.).
Calcium phosphate chromatography. The Brushite form of calcium phosphate was prepared according to the method of Tiselius et al. (25) , and absorption chromatography was carried out by the method of Taverne et al. (24) . Brushite is relatively unstable and was prepared I day prior to chromatography and then was washed overnight with 0.001 M potassium phosphate buffer at pH 7.0. Samples were dialyzed overnight against 0.005 M phosphate, pH 7.0, and added to the columns. All experiments were done at 4 C.
Virus neutralization test. The plaque reduction technique was used in the same manner as previously described (4) . The greatest dilution of serum causing a 50% reduction of the plaque count (on BHK cell monolayers) as compared with virus-preimmune serum mixtures was selected as the neutralizing titer.
Serum blocking activity. The technique used was essentially that of Zwartouw and Westwood (37) . Viral-specific antisera were employed at a dilution capable of reducing the number of HSV PFU by 50%. Extracts prepared from infected or uninfected cells, at various protein concentrations, were incubated with the antiserum for 1 hr at 37 C. A known quantity of HSV was then added to the antigen-antibody mixture, incubated for 1 hr, and plated on BHK monolayers. The surviving virus was titrated as described previously (4) . Control mixtures consisted of: (i) HSV incubated with diluent and preimmune rabbit serum; and (ii) HSV incubated with viral-specific antiserum at a dilution allowing 50%7c survival. The capacity of an antigenic preparation to block the virus-neutralizing ability of an antiserum was calculated according to the following equation: (b -a) (b -c) X 100 = percent of serum blocking capacity.
Immunological techniques. Gel diffusion was performed on Plexiglas templates by the method of Crowle (5) (Pharmacia) (1, 6) . Briefly, Sepharose 2B (14-ml settled volume) was mixed with an equal volume of cyanogen bromide at 25 mg/ml. The pH was immediately adjusted to, and maintained at, 11 to 11.5 with 2 N NaOH (ca. 8 (21) and Weber and Osborn (34) . Gels were standardized with the following purified proteins: cytochrome c (12,000 daltons), chymotrypsin (25, Peripheral wells: 1, BHK-SAM (protein concentration, 5 .2 mg/nil); 2, KB-SAM (4.8 mg/ml); 3, uninlfected KB cell extract (7.9 mg/nl); 4, uninJected BHK cell extract (8.3 mg/n.l).
at least six viral-induced antigens were synthesized after infection regardless of the host cell employed for preparation of SAM.
Separation of a single viral-induced immunoprecipitin from HSV-SAM by calcium phosphate (Brushite) chromatography. Figure 2 shows the elution profile of HSV-SAM proteins removed from a Brushite column in a stepwise fashion with increasing concentrations of phosphate buffer. The eluate was pooled in four fractions as indicated in Fig. 2 , dialyzed against 0.01 M phosphate buffer, pH 7.2, and concentrated. Examination of the individually pooled column fractions by gel diffusion, with anti-SAM sera, showed partial separation of precipitating antigens.
The antigenic content of each fraction was evaluated further by preparing specific antisera against each pooled fraction (anti-CP-1, 2, 3, and 4). Figure 3a (and see diagram in Fig. 3b) indicates that anti-CP-1 serum reacted with HSV-SAM to yield one immunoprecipitin band. The specificity of the antiserum suggested that fraction CP-1 contained only one viral-induced immunoprecipitin. This interpretation was supported by the reciprocal experiment in which fraction CP-1 was reacted against serum, anti-CP-1 serum, and hum globulin. Only one band of identity w with the three sera (Fig. 3c) Table 1 illustrates that rabbit antiserum against virus-free HSV-SAM proved highly efficient in neutralizing HSV infectivity. The antiserum neutralized virus infectivity by 50%O at a dilution of approximately 1 to 800. Rabbit antiserum prepared against virus-free CP-1 fraction exhibited an equivalent virusneutralizing capacity. Human gamma globulin also neutralized virus infectivity, but to a lesser extent. We conclude that the viral-specific immunoprecipitin contained in fraction CP-1 is involved in the stimulation of neutralizing antibody. Furthermore, this biological function suggests that fraction CP-1 contains a structural component of the virus associated with the enveloped surface.
Isolation of CP-1 immunoprecipitin from HSV-SAM employing an immunosorbent. The next series of experiments was designed to explore further the idea that the CP-1 immunoprecipitin was responsible for the production of virusneutralizing antibody. This concept would be reinforced if we could show that the CP-1 immunoprecipitin retained the same biological activity after being separated from the other viral antigens by a different method. The method we chose involved the use of the specific antiserum to CP-1 (gamma globulin fraction) for preparation of a cyanogen bromide-linked immunosorbent (1, 6). The CP-1 antigen was then selectively separated from the mixture of viral antigens in HSV-SAM by affinity chromatography. The effectiveness of the procedure depends in part upon obtaining antibody that reacts specifically with viral antigen and does not react with hostspecific antigens. To achieve this, anti-CP-1 gamma globulin was thoroughly absorbed with uninfected BHK cell extracts (and fetal calf serum) until it reacted only against the CP-1 antigen. Figure 4 illustrates the protein and radioactive (Fig. 5) illustrates that the immunosorbent selectively separated antigen CP-1 from the crude mixture of host and viral-induced antigens. Only one immunoprecipitin band was detected when fraction 2 was reacted against anti-SAM serum, and this band showed identity with fraction CP-1 antigen (isolated from Brushite) and a corresponding band in HSV-SAM. Furthermore, only one band was observed when fraction 2 was reacted against absorbed anti-CP-1 serum or human gamma globulin. No host-specific immunoprecipitin bands were detected when unabsorbed anti-CP-1 serum was reacted against this fraction. Thus, as judged by immunological criteria, this technique apparently effected the isolation of the CP-1 immunoprecipitin from a mixture of viral-induced and host-specific antigens.
VOL. 10, 1972 FIG. 5 . Gel diffusionz anialysis of fractionis eluted from the immunosorbenit prepared with aniti-CP-1 gamma globulin. Center well: anzti-SAM serum. Peripheral wells: 1, fraction CP-J (see Fig. 2 ) (proteini concentration, 0.8 mg/ml); 2, uninifected BHK cell extract (protein contcentration, 8 .3 mg/ml); 3, pooled fraction I (see Fig. 4 ) (proteini concenitrationi, 5 .0 mg/rl); 4, pooled fractioni 2 (see Fig. 4 Blocking of the neutralizing capacity of antiserum by various antigen preparations. The following experiments were performed to determine the relationship between the neutralizing activity of anti-CP-1 serum and the immunoprecipitin band isolated from the immunosorbent. We reasoned that, if the CP-1 immunoprecipitin eluted with LiCl from the immunosorbent had the same biological activity as the fraction CP-1 isolated from calcium phosphate, then it should also be capable of blocking the neutralizing capacity of viral-specific antisera. We determined the capacity of various antigen preparations to block virusneutralizing activity. Table 2 shows that extracts of uninfected BHK cells (800 ,g of protein) had no effect on the neutralizing capacity of the sera tested. In contrast, HSV-SAM, at a concentration of 100 ug of protein, completely blocked neutralizing activity. Far less CP-1 (10 Ag of protein) isolated from the immunosorbent was required to block the neutralizing activity of anti-SAM and anti-CP-1 sera. These results suggest that the fraction CP-1 (Brushite) and the antigen eluted from the immunosorbent (fraction 2) share the same biological activity as well as the same properties in gel diffusion.
Evidence that CP-1 antigen is a glycoprotein. Recent studies employing acrylamide gel electrophoresis have shown that several proteins from whole HSV-infected cells, as well as partially purified viruses and purified smooth membranes, are glycoproteins (11, 12, 19) . Figure 6 shows the SDS-acrylamide gel radioactive pattern of the complete spectrum of 3H-glucosamine-labeled SAM proteins subjected to co-electrophoresis with '4C-valine-labeled SAM. The total spectrum of glycopeptides synthesized by HSV-HF-infected BHK cells form one major peak (peak 1, fraction 12 to 20) with two shoulders at fraction Fig. 4 ). 17 and 19 and three smaHler peaks of radioactivity (peak 2, fractions 21 to 25; peak 3, fractions 25 to 28; peak 4, fractions 29 to 34). The estimated molecular weights (21, 34) for these glycopeptides are peak 1, 100,000; peak 2, 76,000; peak 3, 70,000; and peak 4, 50,000. Although recent reports indicate that certain polypeptide chains covalently linked to carbohydrate migrate at rates which are not proportional to their molecular mass (2, 20) , this does not appear to be true for herpesvirus glycoproteins (23) . The general profile of 3H-glucosamine-labeled proteins obtained here strongly resembles the pattern of glycoproteins reported by Olshevsky and Becker (11) , as well as the pattern seen in Hep-2 cells infected with HSV strain F (8) .
To determine whether the CP-1 antigen was a glycoprotein, BHK cells were labeled with 3H-glucosamine 3 hr after infection with HSV and harvested 14 hr later. Newly synthesized HSVspecific proteins are preferentially glycosylated during this interval (11, 22) . HSV-SAM was prepared as described in Materials and Methods and passed through the CP-1 immunosorbent (see Fig.  4 ) to separate the CP-1 immunoprecipitin from the remaining viral and host antigens. Tritiated glucosamine-labeled CP-1 antigen, isolated from the immunosorbent, was denatured by treatment with SDS, urea, and mercaptoethanol and subjected to SDS-acrylamide electrophoresis (Fig.  7A) . The radioactive profile indicates the presence of a number of glycopeptide bands. However, for the purpose of this report, we will consider only three areas: peak 1 (fraction 13 to 20, estimated molecular weight of 100,000), peak 2 (fraction 30 to 35, estimated molecular weight of 50,000), and the plateau of radioactivity observed between peak 1 and 2 (estimated molecular weight of 70,000). Fig. 7B shows the radioactive profile obtained when 3H-valine-labeled CP-1 antigen (Fig. 4) was treated in the same manner as 3H-glucosamine-labeled antigen. A comparison of the two patterns ( Fig. 7A and B) indicates that the CP-1 antigen is composed of a number of polypeptides migrating to the same relative positions as the glycopeptides. Since the radioactive profiles are similar, we suggest that the CP-1 antigen (LiCl fraction), which displays a less complex radioactive profile than that shown by HSV-SAM (Fig. 6 ), is associated with carbohydrate. However, further studies are necessary to adequately characterize the CP-1 antigen.
Evidence which suggests that the 3H-glucosamine was incorporated directly into the CP-1 immunoprecipitin is as follows. Tritiated glucosamine-labeled CP-1 (from the immunosorbent) was reacted in gel diffusion with anti-CP-1 serum. After development of the pattern, the agar was washed repeatedly with saline, and the immuno- (Fig. 4) Watson and Wildy (32) to refer to the antiserum as monoprecipitin rather than monospecific.
The need for monoprecipitin sera has been emphasized often (12, 30, 32, 33) . As pointed out by Watson and Wildy (32) , for example, studies of the cellular location of HSV-specific antigens by fluorescence microscopy, as well as kinetic studies on the appearance of the antigens during the growth cycle of the virus, are hampered by the polyvalency of the antisera.
Several lines of evidence suggest that the CP-1 immunoprecipitin is a viral-specific antigen. First, specific antiserum which had been repeatedly absorbed with uninfected BHK extracts and serum still retained the capacity to react in gel diffusion with CP-1 antigen. Secondly, anti-CP-1 serum reacted in gel diffusion with HSV-SAM to yield one precipitin band in identity with the band formed against human gamma globulin, as well as the band formed against CP-1. If the CP-1 fraction had contained infectious virus, noninfectious virus, or more than one soluble antigen, one would have expected to find antibodies produced to these viral products. If there were other viralspecific antigens present in CP-1, we were unable to detect them by our methods. Finally, the CP-1 immunoprecipitin stimulated the production of HSV-neutralizing antibody of high capacity. This last observation suggests that CP-1 is a virus structural component which is associated with the envelope of the virus. Alternatively, a host protein associated with the viral envelope rather than the viral-specific CP-1 antigen could be involved in virus neutralization. Evidence to support this alternative was presented by Watson and Wildy (31) , who showed that anti-host cell serum agglutinated the envelope particles of HSV. However, no neutralization data were presented by these authors. Becker and Olshevsky (11) also found cellular proteins in preparations of the enveloped virus. On the other hand, Spear and Roizman (23) recently presented evidence that cellular proteins are probably not components of highly purified mature virions. We believe it is unlikely that the neutralizing activity associated with CP-1 antigen was due to a host-derived protein since antiserum to this antigen did not react with normal BHK components by immunodiffusion. In addition, large amounts of uninfected BHK protein failed to block the neutralizing capacity of anti-CP-1 or anti-SAM serum, whereas very small amounts of CP-1 blocked these sera completely. It was unlikely that the serum-blocking effect of the CP-1 preparation was due to virus, since no infectious virus could be detected in the plaque assay nor were any virus particles observed by electron microscope examination of CP-1 (unpublished results).
The hyperimmune antisera used in these experiments are probably comparable to "late" 7S antibody described by Hampare (7 (12) , hemadsorption (29) , and immunologic injury or cytolytic effect (13, 16) . Roizman (12) has reviewed the evidence indicating that the "new" antigen(s) found on the surface of HSVinfected cells is a structural component of the virus envelope. Furthermore, all of the glycoproteins found in the mature HSV apparently are associated with the envelope of the virus (11, 23) . It was also observed that there is a strong correlation between neutralizing antibody titers and cytolytic (15) and hemadsorption-inhibition titers (29) , suggesting that the antigen which stimulates production of neutralizing antibody may also be responsible for these other phenomena. Since fraction CP-1 stimulated neutralizing antibody, it may be hypothesized that the antigen CP-1 is responsible for some or all of the altered properties of the infected cells. The monoprecipitin anti-CP-1 serum should be useful for studying these phenomena.
On the basis of SDS-polyacrylamide gel electrophoresis, the CP-1 antigenic fraction isolated from the immunosorbent appeared to contain a number of radioactively labeled polypeptides and glycopeptides. This observation may be explained in several ways. (i) The CP-1 antigen derived from HSV-SAM was a complex or aggregate of several viral-specific proteins. When the radioactive HSV-SAM was passed through the immunosorbent, the CP-1 antigen combined with the specific anti-CP-1 antibody and carried the contaminating or complexed proteins with it. (ii) The anti-CP-1 serum used for preparation of the immunosorbent was polyvalent and contained low concentrations of antibody to several virus structural components other than CP-1. Low concentrations of several radioactively labeled, viralspecific proteins would attach to the immunosorbent and after elution would be detected by acrylamide gel electrophoresis, but not by immunodiffusion. (iii) The CP-1 antigen was made up of a number of different subunits or molecular forms containing varying amounts of lipid or carbohydrate residues.
Further studies are now in progress to purify and characterize the CP-1 immunoprecipitin.
